期刊文献+

血管形成抑制剂TNP-470对小鼠肝癌术后复发和转移防治的研究 被引量:2

EXPERIMENTAL STUDY OF PREVENTION AND TREATMENT EFFECT OF TNP-470 ON THE RECURRENCE AND METASTASIS OF THE MICE BEARING HEPATOCELLULAR CARCINOMA
下载PDF
导出
摘要 目的 研究血管形成抑制剂TNP 470对小鼠原位移植性肝癌术后复发和转移的防治作用。方法 原位肝癌模型小鼠切除肿瘤后建成肝癌切除术后小鼠模型 3 0只 ,随机分为 2组 :对照组隔日皮下注射 3 %酒精溶剂 ;TNP 470组隔日皮下注射TNP 470 ( 3 0mg/kg) ;用药至小鼠死亡。检测小鼠存活时间、各组复发率、复发瘤体积、处理前后腹围。 结果 TNP 470组较对照组生存时间明显延长 (P <0 0 5 ) ;TNP 470组较对照组复发率明显减少 ,复发瘤体积亦减小 (P <0 0 5 ) ;TNP 470组较对照组小鼠腹围明显减少 (P <0 0 5 )。结论 TNP Objective: To evaluate whether TNP-470 could prevent the recurrence and metastasis of the KM mice bearing hepatocellular carcinoma. Methods: The tumor was resected to construct the model of postoperative mice, thirty of which were randomized into 2 groups: control (3% ethanol, sc,qod), TNP-470 (30 mg/kg, sc, qod) and detect the survival time; the ratio of recurrence, the longest and perpendicular dimension (a, b) of the recurrent tumor, the pre-treatment and post-treatment abdomen circumference of the mice. Results: the survival time of the TNP-470 group was longer than the control group(P<0.05); the ratio of recurrence and the volume of the recurrent tumor of the TNP-470 group was lower than the control group(P<0.05); the abdomen circumference of the TNP-470 group was shorter the control group (P<0.05). Conclusion: TNP-470 could prevent the recurrence and metastasis of the KM mice bearing hepatocellular carcinoma.
出处 《实用临床医药杂志》 CAS 2004年第1期45-47,共3页 Journal of Clinical Medicine in Practice
关键词 TNP-470 肝癌 复发 转移 TNP-470 liver cancer recurrence metastasis
  • 相关文献

参考文献9

  • 1Tang Z Y, Yang B H. Secondary prevention of hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 1995, 10: 683.
  • 2Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease[J]. Nat Med, 1995, 1: 27.
  • 3Liotta L A, Kleinerman J, Saidel G M. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonaxy metastases following tumor implatation [J]. Cancer Res, 1974, 34(5): 997.
  • 4Folkman J. Tumor angiogenesis and tissue factor[J]. Nat Med, 1996, 2(2): 167.
  • 5Holmgren L, O'Relly M S, Folkman J, et al. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression[J]. Nat Med, 1995, 1(2): 149.
  • 6Gervaz P, Scholl B, Padrun V, et al. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470[J]. Liver.2000, 20(2): 108.
  • 7Boehm T. Anti-angiogenic therapy of experimental cancer does not induce acquired drug resistence[J]. Nature, 1997. 390:404.
  • 8Isaiah J, Fidler M, Lee M. The implications of angiogenesis for the biology and therapy of cancer metastasis[J]. Cell,1994, 79: 185.
  • 9Marcia B. Designing therapyies that targer tumor blood vessels[J]. Science, 1997, 275: 482.

同被引文献13

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部